Halometasone
From Wikipedia, the free encyclopedia
Halometasone
|
|
Systematic (IUPAC) name | |
(6S,8S,9R,10S,11S,13S,16R,17R)-2-chloro- 6,9-difluoro-11,17-dihydroxy-17-(2-hydroxy acetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15, 16-octahydrocyclopenta[a]phenanthren-3-one |
|
Identifiers | |
CAS number | |
ATC code | D07 |
PubChem | |
Chemical data | |
Formula | C22H27ClF2O5 |
Mol. mass | 444.896 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Halometasone is a corticosteroid.